Install our extension to search inside any video instantly.

Immunology Question of the Day | Clinical Case Discussion by Dr. Mukesh Bhatia

Added:
117 views15likes3:19Dr.BhatiaAcademyOriginal Release: 2026-07-21

Macrophage Activation Syndrome (MAS) is a life-threatening hyperinflammatory syndrome characterized by uncontrolled macrophage and cytotoxic T-cell activation, most commonly complicating systemic juvenile idiopathic arthritis (sJIA) and adult-onset Still's disease. The hallmark diagnostic features include extreme hyperferritinemia (serum ferritin >15,000 ng/mL), pancytopenia, elevated triglycerides, hypofibrinogenemia, and elevated liver enzymes. Early recognition is critical because delayed treatment carries very high mortality. Initial treatment consists of high-dose corticosteroids with anakinra (an IL-1 inhibitor) for refractory cases. Clinicians should always suspect MAS in sJIA patients who suddenly deteriorate with extreme hyperferritinemia.